VULVOVAGINAL ERYTHEMA

This adverse event was reported 836 times

These drugs are most commonly taken by patients reporting VULVOVAGINAL ERYTHEMA:

# Drug Count
0 MICONAZOLE NITRATE 115
1 ESTRADIOL 92
2 TIOCONAZOLE 52
3 CONJUGATED ESTROGENS 49
4 ESTROGENS, CONJUGATED 49
5 METHOTREXATE SODIUM 43
6 ADALIMUMAB 42
7 METHOTREXATE 42
8 SECUKINUMAB 30
9 CELECOXIB 28
See all common drugs associated with VULVOVAGINAL ERYTHEMA

VULVOVAGINAL ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TIOCONAZOLE 52 0.0337
1 OTESECONAZOLE 1 0.0233
2 MICONAZOLE NITRATE 115 0.0130
3 CLOBETASOL PROPIONATE CREAM USP, 0.05% 1 0.0101
4 CLINDAMYCIN PHOSPHATE AND TRETINOIN 1 0.0065
5 DINOPROSTONE 5 0.0061
6 LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE 1 0.0055
7 OSPEMIFENE 14 0.0054
8 ACITRETIN 26 0.0053
9 ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE 6 0.0044
See all drugs enriched for association with VULVOVAGINAL ERYTHEMA

VULVOVAGINAL ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen Agonist/Antagonist [EPC] 14 0.0054
1 Interleukin-17A Antagonist [EPC] 30 0.0008
2 Estrogen [EPC] 148 0.0008
3 Provitamin D2 Compound [EPC] 17 0.0006
4 Pyrethroid [EPC] 1 0.0006
5 Azole Antifungal [EPC] 85 0.0005
6 Non-Standardized Fungal Allergenic Extract [EPC] 1 0.0005
7 Antiseptic [EPC] 2 0.0005
8 Gonadotropin [EPC] 1 0.0005
9 Tyrosine Kinase 2 Inhibitor [EPC] 1 0.0003
See all drug classes enriched for association with VULVOVAGINAL ERYTHEMA